Potential Impact of Probiotics on Human Health and Prospects in Clinical Application

Authors

  • Jinhao Zhu

DOI:

https://doi.org/10.61173/jeammm27

Keywords:

Probiotics, intestinal microbiota, immune system, gut-brain axis, metabolic mechanism

Abstract

This article discusses the detailed effects of probiotics and the potential uses in curing diseases. Research shows that certain living organisms can bring about the following benefits for man; they help maintain the ratio of the good bacteria in the intestines, improve the immune system, reduce allergic reactions, aid intestinal movement and digestion. On the other hand, probiotics may also help to modulate emotions, cognition, and stress by influencing the communication between the gut-brain axis and neurotransmitter. Furthermore, the identified probiotic metabolites, the short-chain fatty acids, are involved in metabolic processes within the intestine and other organs. Probiotics also have some anti-cancer, anti-disease and anti-inflammatory effects, and can suppress pathogens and inflammation by affecting immune cells. This article also discusses the link between probiotics in the intestinal and nervous system diseases and chronic diseases and their roles in future medical science and clinical practice. Most of the current research work is done on probiotics is done in vitro and animal studies and future clinical study has to be undertaken to ascertain their mechanisms and effectiveness in human beings.

References

[1] Wu Z.-x., Li S.-s., Shen X., Li M., Cui W.-j., Zhang Q.-s., He F. Effects on immunomodulatory of probiotics. Food Science and Technology, 2017, 42(01): 29-34.

[2] Hamasalim H.J. Synbiotic as feed additives relating to animal health and performance. Adv Microbiol, 2016, 6: 288-302.

[3] Bongaerts G.P.A., Severijnen R.S.V.M. A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nature Biotechnol, 2016, 34: 55-63.

[4] Islam S.U. Clinical uses of probiotics. Medicine (Baltimore), 2016, 95: 1-5.

[5] Ooi M.F., Mazlan N., Foo H.L., Loh T.C., Mohamad R., Rahim R.A., et al. Effects of carbon and nitrogen sources on bacteriocin-inhibitory activity of postbiotic metabolites produced by Lactobacillus plantarum I-UL4. Malays J Microbiol, 2015, 11: 176-184.

[6] Giorgetti G.M., Brandimarte G., Fabiocchi F., Ricci S., Flamini P., Sandri G., et al. Interactions between innate immunity, microbiota, and probiotics. J Immunol Res, 2015, 501361: 1-7.

[7] Rastall R.A., Gibson G.R. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr Opinion Biotechnol, 2015, 32: 42-46.

[8] Hutkins R.W., Krumbeck J.A., Bindels L.B., Cani P.D., Fahey G., Goh Y.J., et al. Prebiotics: why definitions matter. Curr Opin Biotechnol, 2016, 37: 1-13.

[9] Tufarelli V., Laudadio V. An overview on the functional food concept: prospectives and applied researches in probiotics, prebiotics and synbiotics. J Exp Biol Agric Sci, 2016, 4: 274- 278.

[10] Tejero-Sarinena S., Barlow J., Costabile A., Gibson G.R., Rowland I. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains? Anaerobe, 2013, 24: 60-65.

[11] World Health Organization. Cancer fact sheet 2024. World Health Organization, IARC, 2024.

[12] Vafaeie F. Critical review on probiotics and its effect on cancer. Cancer Press, 2016, 2: 30-34.

[13] So S.S., Wan M.L., El-Nezami H. Probiotics-mediated suppression of cancer. Curr Opinion Oncol, 2017, 29: 62-72.

[14] Kahouli I., Malhotra M., Alaoui-Jamali M.A., Prakash S. Invitro characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum NCIMB 5221 and potential against colorectal cancer cells. J Cancer Sci Ther, 2015, 7: 224- 235.

[15] Awaisheh S.S., Obeidat M.M., Al-Tamimi H.J., Assaf A.M., EL Qudah J.M., Al-khazaleh J.M., et al. In vitro cytotoxic activity of probiotic bacterial cell extracts against Caco-2 and HRT-18 colorectal cancer cells. Milk Sci Int, 2016, 69: 27-31.

[16] Akelma A.Z., Topcu Z.I.K. Probiotics and allergic disease. World J Immunol, 2016, 6I: 75-82.

[17] Song S., Lee S.J., Park D.-J., Oh S., Lim K.-T. The anti-allergic activity of Lactobacillus plantarum L67 and its application to yogurt. J Dairy Res, 2016, 99: 9372-9382.

[18] Takeda S., Hidaka M., Yoshida H., Takeshita M., Kikuchi Y., Tsend-Ayush C., et al. Antiallergic activity of probiotics from Mongolian dairy products on type I allergy in mice and mode of antiallergic action. J Funct Foods, 2014, 9: 60-69.

Downloads

Published

2025-06-26